Literature DB >> 28116521

In hepatic venous outflow obstruction, alcoholic liver disease, and nonalcoholic fatty liver disease, centrilobular scars, CD34+ vessels, and keratin 7+ hepatocytes are in close proximity.

Susumu Matsukuma1,2, Hiroaki Takeo3, Yoshitaka Utsumi3, Kimiya Sato3.   

Abstract

For hepatic venous outflow obstruction, alcoholic liver injury, and nonalcoholic fatty liver disease, the term "centrizonal injury disease" (CID) is used, because injury patterns in all three entities are similar. To elucidate CID-related CD34+ vessels (sinusoids and/or microvessels) and keratin 7+ hepatocytes (K7+ Hs), we examined a series of 41 liver tissue specimens obtained at autopsy and surgery, consisting of 32 CID cases and 9 controls. Centrizonal scars were found in 21 CID cases, and these were associated with centrizonal CD34+ vessels (P = 0.009) and centrizonal K7+ Hs (P < 0.001). Centrizonal coexistence of CD34+ vessels and K7+ Hs was observed in 22 CID cases (P = 0.057). These findings suggest close centrizonal proximity of scar, CD34+ vessels, and K7+ Hs in CID. However, centrizonal K7+ Hs without CD34+ vessels were observed in 21 CID cases. CD34+ vessels were detectable in all control samples and may represent the normal vascular bed. In 29 CID cases, centrizonal CD34+ vessel density was higher than that in controls. However, most appeared to be continuous with periportal and/or interlobular CD34+ vessels, and those CD34+ vessels restricted to centrizonal regions were focal and limited in seven CID cases. Centrizonal CD34+ vessels were associated with venoportal adhesions (P = 0.027). Our findings suggest that CID induces both venoportal adhesion-related structural distortion and expansion of normally present CD34+ vessels, which may result in increased centrizonal CD34+ vessel density.

Entities:  

Keywords:  Alcoholic liver disease; CD34; Cytokeratin 7; Hepatic progenitor cell; Hepatic venous outflow obstruction; Immunohistochemistry; Keratin 7; Liver; Microvessel; Niches; Nonalcoholic fatty liver disease; Sinusoidal endothelial cell; Sinusoidal vascular beds

Mesh:

Substances:

Year:  2017        PMID: 28116521     DOI: 10.1007/s00428-017-2074-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

1.  Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis.

Authors:  Jennifer A Eleazar; Lorenzo Memeo; Jeffrey S Jhang; Mahesh M Mansukhani; Steven Chin; Soo Mi Park; Jay H Lefkowitch; Govind Bhagat
Journal:  J Hepatol       Date:  2004-12       Impact factor: 25.083

2.  CD34 expression in noncancerous liver tissue predicts multicentric recurrence of hepatocellular carcinoma.

Authors:  Naoko Tsuji; Shingo Ishiguro; Yo Sasaki; Masatoshi Kudo
Journal:  Dig Dis       Date:  2013-11-21       Impact factor: 2.404

3.  The hepatic stem cell niche: identification by label-retaining cell assay.

Authors:  Reiichiro Kuwahara; Alexander V Kofman; Charles S Landis; E Scott Swenson; Els Barendswaard; Neil D Theise
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

4.  The immunology of fibrogenesis in alcoholic liver disease.

Authors:  Antonio Chedid; Selma Arain; Ann Snyder; Philippe Mathurin; Frédérique Capron; Sylvie Naveau
Journal:  Arch Pathol Lab Med       Date:  2004-11       Impact factor: 5.534

5.  Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.

Authors:  I R Wanless; E Nakashima; M Sherman
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

6.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

7.  Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.

Authors:  Marc P Pusztaszeri; Walter Seelentag; Fred T Bosman
Journal:  J Histochem Cytochem       Date:  2005-10-18       Impact factor: 2.479

8.  Angiogenesis in chronic liver disease.

Authors:  Anjali D Amarapurkar; Deepak N Amarapurkar; S Vibhav; Nikhil D Patel
Journal:  Ann Hepatol       Date:  2007 Jul-Sep       Impact factor: 2.400

9.  Atrophic hepatocytes express keratin 7 in ischemia-associated liver lesions.

Authors:  Ioanna Delladetsima; Stratigoula Sakellariou; Aikaterini Kokkori; Dina Tiniakos
Journal:  Histol Histopathol       Date:  2016-02-18       Impact factor: 2.303

10.  Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C.

Authors:  Hwajeong Lee; Sanaz Ainechi; Karen Dresser; Elizabeth M Kurian
Journal:  Int J Hepatol       Date:  2014-11-30
View more
  3 in total

1.  Expression of 6 Biomarkers in Liver Grafts After Pediatric Liver Transplantation: Correlations with Histology, Biochemistry, and Outcome.

Authors:  Silja H Voutilainen; Silja K Kosola; Jouko Lohi; Aino Mutka; Timo Jahnukainen; Mikko Pakarinen; Hannu Jalanko
Journal:  Ann Transplant       Date:  2020-10-16       Impact factor: 1.530

2.  Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism).

Authors:  Johanna Sivunen; Susann Karlberg; Reetta Kivisaari; Jouko Lohi; Niklas Karlberg; Eero Jokinen; Taisto Sarkola; Timo Jahnukainen; Marita Lipsanen-Nyman; Hannu Jalanko
Journal:  Liver Int       Date:  2022-03-08       Impact factor: 8.754

3.  Keratin 7 expression in hepatic cholestatic diseases.

Authors:  S Sakellariou; C Michaelides; T Voulgaris; J Vlachogiannakos; E Manesis; D G Tiniakos; I Delladetsima
Journal:  Virchows Arch       Date:  2021-07-27       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.